Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database (original) (raw)

Fig. 1. Flow of selection of the study population. HCC, hepatocellular carcinoma; ICD-10, International Classification of Disease 10th edition; BCLC, Barcelona Clinic Liver Cancer; CSE, conditional survival estimate(s).

Fig. 2. Kaplan-Meier curves for cumulative survival rate of each Barcelona Clinic Liver Cancer (BCLC) stage in cohort A diagnosed in 2008-2010 (A) and cohort B diagnosed in 2011-2012 (B). Log-rank tests between any groups; p < 0.001.

Fig. 3. One-year conditional survival estimates of overall patients and each Barcelona Clinic Liver Cancer (BCLC) stage in cohort A diagnosed in 2008-2010 (A) and cohort B diagnosed in 2011-2012 (B). "X" yr or "X" mo, 1-year conditional survival estimates at the time of "X"-year or "X"-month survival.

Fig. 4. One-year conditional survival estimates of each Barcelona Clinic Liver Cancer (BCLC) subgroup using initial treatment methods in cohort A, in BCLC 0 (A), BCLC A (B), and BCLC B (C). "X" yr, 1-year conditional survival estimates at the time of "X"-year survival.

Fig. 5. One-year conditional survival estimates of each Barcelona Clinic Liver Cancer (BCLC) subgroup using initial treatment methods in cohort B, in BCLC 0 (A), BCLC A (B), and BCLC B (C). "X" yr or "X" mo, 1-year conditional survival estimates at the time of "X"-year or "X"-month survival.